Birth cohort effects underlying the increasing testicular cancer incidence in Canada

被引:26
作者
Liu, SL
Wen, SW
Mao, Y
Mery, L
Rouleau, J
机构
[1] Lab Ctr Dis Control, Bur Reprod & Child Hlth, Ottawa, ON K1A 0L2, Canada
[2] Lab Ctr Dis Control, Canc Bur, Ottawa, ON K1A 0L2, Canada
来源
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE | 1999年 / 90卷 / 03期
关键词
D O I
10.1007/BF03404502
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: To examine the pattern of testicular cancer incidence by age, time period and birth cohort since 1969 in Canada. Method: In addition to analyses of the secular trends by age group and birth cohort separately, an age-period-cohort model and the submodels with standard Poisson assumptions were fitted to the data. Results: The overall age-adjusted incidence of testicular cancer increased in Canada, from 28 per 100,000 males in 1969-71 to 4.2 in 1991-93. The younger age groups showed much higher absolute incidence rates in the recent period compared with those in the early period: Age-period-cohort modelling of data restricted to males aged 20-84 years suggested that the observed increase in testicular cancer could be largely attributed to a birth cohort effect. A steady increase in risk was observed among men bon since 1945; those born between 1959 and 1968 were 2.0 (95% CI, 1.5 26) times as likely to develop testicular cancer has increased over time and changing exposure to environmental factors early in life may be responsible for this.
引用
收藏
页码:176 / 180
页数:5
相关论文
共 19 条
[12]  
HORWICH A, 1995, OXFORD TXB ONCOLOGY, V2, P1407
[13]  
LE ND, 1995, CANADIAN CANC INCIDE, V1, P20
[14]   TRENDS IN INCIDENCE OF TESTICULAR CANCER IN BOYS AND ADOLESCENT MEN [J].
MOLLER, H ;
JORGENSEN, N ;
FORMAN, D .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (06) :761-764
[15]  
*NAT I CAN, 1997, CAN CANC STAT, P15
[16]  
*SAS I INC, 1993, P243 SAS I INC, P1
[17]   Trends in incidence of testicular cancer in Norway 1955-1992 [J].
Wanderas, EH ;
Tretli, S ;
Fossa, SD .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (12) :2044-2048
[18]  
Zheng TZ, 1996, INT J CANCER, V65, P723, DOI 10.1002/(SICI)1097-0215(19960315)65:6<723::AID-IJC2>3.0.CO
[19]  
2-0